Answer
Patients should not drive or operate machinery if dizziness or visual disturbances occur within 24 hours after Campto (irinotecan) administration.
Sources for this answer
- Campto 20mg/ml concentrate for solution for infusion (40mg presentation)Pfizer Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 27Document updated
Sources checked